New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Aptevo Therapeutics Inc.
APVO
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

2M

Biotechnology

Next Earning date - 14 Aug 2025

2M

Biotechnology

Next Earning date - 14 Aug 2025

2.95USD

Shape-0.10 ( -3.28%)
Market Closed (as of Jul 01, 20:00 EDT)
favorite-chart

Relative Strenght

24
favorite-chart

Volume Buzz

-91%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

99%

Quote Panel

Shape
Updated July 2, 2025
1W -8.67 % 1M -40.64 % 3M -92.59 % 1Y -98.73 %

Key Metrics

Shape
  • Market Cap

    2.10M


  • Shares Outstanding

    405497


  • Share in Float

    405497


  • Dividende

    0


  • Earning Date

    14 Aug 2025


  • Price Target

    2.95


  • Average Volume

    2.43M


  • Beta

    5.728


  • Range

    2.81-485.44


  • Industry

    Biotechnology


  • Website

    https://www.aptevotherapeutics.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

APVO

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$8M

ShapeNaN%

2026-Revenue

$289.80

Shape-6501%

2026-EPS

$2M

Shape77%

2026-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

NaN(-100.00%)

Number of analyst

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q2.23

arrow
arrow

N/A

-1963.23
vs -2968.78

Q3.23

arrow
arrow

N/A

-798.06
vs -2442.06

Q4.23

arrow
arrow

N/A

-6.16
vs -0.95

Q1.24

arrow
arrow

N/A

-360.51
vs 414.99

Q2.24

arrow
arrow

N/A

-60.51
vs -1963.23

Q3.24

arrow
arrow

N/A

-17.39
vs -798.06

Q4.24

arrow
arrow

N/A

-82.37
vs -6.16

Q1.25

arrow
arrow

N/A

-87.80
vs -360.51

Q2.25

arrow
arrow

N/A

-83.20
vs -60.51

Q3.25

arrow
arrow

N/A

-75.60
vs -17.39

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

-185%

-3114000.00  vs 3.7M

Q1.23

arrow
arrow

-100%

NA  vs 3.1M

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

+129%

902K  vs -3114000

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

NA  vs NA

Q3.24

arrow
arrow

NA

NA  vs NA

Q4.24

arrow
arrow

-100%

NA  vs 902K

Q1.25

arrow
arrow

NA

NA  vs NA

Return on EquityShape

status-upQoQ

Q2.23

arrow
arrow

-49%

-0.49
vs 0.49

Q3.23

arrow
arrow

-43%

-0.43
vs -0.49

Q4.23

arrow
arrow

-48%

-0.48
vs -0.43

Q1.24

arrow
arrow

-112%

-1.12
vs -0.48

Q2.24

arrow
arrow

-132%

-1.32
vs -1.12

Q3.24

arrow
arrow

-115%

-1.15
vs -1.32

Q4.24

arrow
arrow

-133%

-1.33
vs -1.15

Q1.25

arrow
arrow

+435%

4.35
vs -1.33

Institutionnal OwnershipShape

status-upQoQ

Q1.22

arrow
arrow

18

18
vs 18

NA

Q2.22

arrow
arrow

20

20
vs 18

11%

Q3.22

arrow
arrow

20

20
vs 20

NA

Q4.22

arrow
arrow

26

26
vs 20

30%

Q1.23

arrow
arrow

24

24
vs 26

-8%

Q2.23

arrow
arrow

23

23
vs 24

-4%

Q3.23

arrow
arrow

26

26
vs 23

13%

Q4.23

arrow
arrow

30

30
vs 26

15%

Earnings Growth

Latest News